Skip to main content
Top
Published in: Infection 1/2019

01-02-2019 | Original Paper

Health-related quality of life in patients with alveolar echinococcosis: a cross-sectional study

Authors: Julian Schmidberger, Henriette Weimer, Patrycja Schlingeloff, Wolfgang Kratzer, Beate Grüner, Echinococcosis Working Group, Ulm

Published in: Infection | Issue 1/2019

Login to get access

Abstract

Purpose

The Alveolar echinococcosis (AE) is a rare zoonosis caused by the parasite Echinococcus multilocularis. To date, nothing is known about the health-related quality of life (HRQoL) in patients with AE. The aim of the study was to evaluate the HRQoL in patients with AE in comparison of the healthy population.

Methods

We used the 36-Item Short Form Health Survey (SF-36) questionnaire to evaluate the HRQoL. The SF-36 scales have a range of 0–100 (0 represents the worst and 100 the most favourable state of health). SAS Version 9.2 was used for the statistical analysis of AE-cases (n = 30) and the healthy control group (n = 35).

Results

The analysis showed that the HRQoL in people with AE is reduced in comparison with the control population. The study group consisted of 15 (50.0%) men and 15 (50.0%) women; the control group of 16 (45.7%) men and 19 (54.3%) women. The mean age was 55.73 ± 16.65 years, while that of the control group was 54.57 ± 15.34 years. The physical quality of life in patients with AE (45.21 ± 11.42) was not significantly less than that of the control group (50.54 ± 10.52); p = 0.0568. Nevertheless, AE-patients show lower SF-36 scores for the physical quality of life. For the mental quality of life, patients with AE had a significantly lower score (45.46 ± 10.57) than the control group (51.57 ± 9.04); p = 0.0154.

Conclusions

The HRQoL in people with AE is reduced in comparison with a control population. Assessment of the physical and mental quality of life in patients with AE may help to evaluate the patient outcome.
Literature
1.
go back to reference Kern P, Bardonnet K, Renner E, Auer H, Pawlowski Z, Ammann RW, Vuitton DA, Kern P. European echinococcosis registry: human alveolar echinococcosis, Europe, 1982–2000. Emerg Infect Dis. 2003;9:343–9.CrossRefPubMedPubMedCentral Kern P, Bardonnet K, Renner E, Auer H, Pawlowski Z, Ammann RW, Vuitton DA, Kern P. European echinococcosis registry: human alveolar echinococcosis, Europe, 1982–2000. Emerg Infect Dis. 2003;9:343–9.CrossRefPubMedPubMedCentral
3.
go back to reference Romig T, Kratzer W, Kimmig P, Frosch M, Gaus W, Flegel WA, Gottstein B, Lucius R, Beckh K, Kern P. An epidemiologic survey of human alveolar echinococcosis in southwestern Germany. Römerstein Study Group. Am J Trop Med Hyg. 1999;61:566–73.CrossRefPubMed Romig T, Kratzer W, Kimmig P, Frosch M, Gaus W, Flegel WA, Gottstein B, Lucius R, Beckh K, Kern P. An epidemiologic survey of human alveolar echinococcosis in southwestern Germany. Römerstein Study Group. Am J Trop Med Hyg. 1999;61:566–73.CrossRefPubMed
5.
go back to reference Deplazes P, Rinaldi L, Alvarez Rojas CA, Torgerson PR, Harandi MF, Romig T, Antolova D, Schurer JM, Lahmar S, Cringoli G, Magambo J, Thompson RC, Jenkins EJ. Global distribution of alveolar and cystic echinococcosis. Adv Parasitol. 2017;95:315–493.CrossRefPubMed Deplazes P, Rinaldi L, Alvarez Rojas CA, Torgerson PR, Harandi MF, Romig T, Antolova D, Schurer JM, Lahmar S, Cringoli G, Magambo J, Thompson RC, Jenkins EJ. Global distribution of alveolar and cystic echinococcosis. Adv Parasitol. 2017;95:315–493.CrossRefPubMed
6.
go back to reference Craig PS, Deshan L, MacPherson CN, Dazhong S, Reynolds D, Barnish G, Gottstein B, Zhirong W. A large focus of alveolar echinococcosis in central China. Lancet. 1992;340:826–31.CrossRefPubMed Craig PS, Deshan L, MacPherson CN, Dazhong S, Reynolds D, Barnish G, Gottstein B, Zhirong W. A large focus of alveolar echinococcosis in central China. Lancet. 1992;340:826–31.CrossRefPubMed
8.
go back to reference Zhang W, Zhang Z, Wu W, Shi B, Li J, Zhou X, Wen H, McManus DP. Epidemiology and control of echinococcosis in central Asia, with particular reference to the People’s Republic of China. Acta Trop. 2015;141:235–43.CrossRefPubMed Zhang W, Zhang Z, Wu W, Shi B, Li J, Zhou X, Wen H, McManus DP. Epidemiology and control of echinococcosis in central Asia, with particular reference to the People’s Republic of China. Acta Trop. 2015;141:235–43.CrossRefPubMed
9.
go back to reference Craig PS. Epidemiology of human alveolar echinococcosis in China. Parasitol Int. 2006;55:221–5.CrossRef Craig PS. Epidemiology of human alveolar echinococcosis in China. Parasitol Int. 2006;55:221–5.CrossRef
10.
go back to reference Tiaoying L, Jiamin Q, Wen Y, Craig PS, Xingwang C, Ning X, Ito A, Giraudoux P, Wulamu M, Wen Y, Schantz PM. Echinococcosis in Tibetan populations, western Sichuan Province, China. Emerg Infect Dis. 2005;11:1866–73.CrossRefPubMedPubMedCentral Tiaoying L, Jiamin Q, Wen Y, Craig PS, Xingwang C, Ning X, Ito A, Giraudoux P, Wulamu M, Wen Y, Schantz PM. Echinococcosis in Tibetan populations, western Sichuan Province, China. Emerg Infect Dis. 2005;11:1866–73.CrossRefPubMedPubMedCentral
11.
go back to reference Schmidberger J, Kratzer W, Stark K, Grüner B. Alveolar echinococcosis in Germany, 1992–2016. An update based on the newly established national AE database. Infection. 2018;46:197–206.CrossRefPubMed Schmidberger J, Kratzer W, Stark K, Grüner B. Alveolar echinococcosis in Germany, 1992–2016. An update based on the newly established national AE database. Infection. 2018;46:197–206.CrossRefPubMed
12.
13.
go back to reference Eckert J, Deplazes P. Biological, epidemiological, and clinical aspects of echinococcosis, a zoonosis of increasing concern. Clin Microbiol Rev. 2004;17:107–35.CrossRefPubMedPubMedCentral Eckert J, Deplazes P. Biological, epidemiological, and clinical aspects of echinococcosis, a zoonosis of increasing concern. Clin Microbiol Rev. 2004;17:107–35.CrossRefPubMedPubMedCentral
14.
go back to reference Graeter T, Kratzer W, Oeztuerk S, Haenle MM, Mason RA, Hillenbrand A, Kull T, Barth TF, Kern P, Gruener B. Proposal of a computed tomography classification for hepatic alveolar echinococcosis. World J Gastroenterol. 2016;22:3621–31.CrossRefPubMedPubMedCentral Graeter T, Kratzer W, Oeztuerk S, Haenle MM, Mason RA, Hillenbrand A, Kull T, Barth TF, Kern P, Gruener B. Proposal of a computed tomography classification for hepatic alveolar echinococcosis. World J Gastroenterol. 2016;22:3621–31.CrossRefPubMedPubMedCentral
15.
go back to reference Kern P, Ammon A, Kron M, Sinn G, Sander S, Petersen LR, Gaus W, Kern P. Risk factors for alveolar echinococcosis in humans. Emerg Infect Dis. 2004;10:2088–93.PubMedPubMedCentral Kern P, Ammon A, Kron M, Sinn G, Sander S, Petersen LR, Gaus W, Kern P. Risk factors for alveolar echinococcosis in humans. Emerg Infect Dis. 2004;10:2088–93.PubMedPubMedCentral
16.
go back to reference Piarroux M, Piarroux R, Knapp J, Bardonnet K, Dumortier J, Watelet J, Gerard A, Beytout J, Abergel A, Bresson-Hadni S, Gaudart J. Populations at risk for alveolar echinococcosis, France. Emerg Infect Dis. 2013;19:721–8.CrossRefPubMedPubMedCentral Piarroux M, Piarroux R, Knapp J, Bardonnet K, Dumortier J, Watelet J, Gerard A, Beytout J, Abergel A, Bresson-Hadni S, Gaudart J. Populations at risk for alveolar echinococcosis, France. Emerg Infect Dis. 2013;19:721–8.CrossRefPubMedPubMedCentral
17.
go back to reference Kreidl P, Allerberger F, Judmaier G, Auer H, Aspöck H, Hall AJ. Domestic pets as risk factors for alveolar hydatid disease in Austria. Am J Epidemiol. 1998;147:978–81.CrossRefPubMed Kreidl P, Allerberger F, Judmaier G, Auer H, Aspöck H, Hall AJ. Domestic pets as risk factors for alveolar hydatid disease in Austria. Am J Epidemiol. 1998;147:978–81.CrossRefPubMed
18.
go back to reference Lass A, Szostakowska B, Myjak P, Korzeniewski K. Fresh fruits, vegetables and mushrooms as transmission vehicles for Echinococcus multilocularis in highly endemic areas of Poland: reply to concerns. Parasitol Res. 2016;115:3637–42.CrossRefPubMedPubMedCentral Lass A, Szostakowska B, Myjak P, Korzeniewski K. Fresh fruits, vegetables and mushrooms as transmission vehicles for Echinococcus multilocularis in highly endemic areas of Poland: reply to concerns. Parasitol Res. 2016;115:3637–42.CrossRefPubMedPubMedCentral
19.
go back to reference Conraths FJ, Probst C, Possenti A, Boufana B, Saulle R, La Torre G, Busani L, Casulli A. Potential risk factors associated with human alveolar echinococcosis: systematic review and meta-analysis. PLoS Negl Trop Dis. 2017;11:e0005801.CrossRefPubMedPubMedCentral Conraths FJ, Probst C, Possenti A, Boufana B, Saulle R, La Torre G, Busani L, Casulli A. Potential risk factors associated with human alveolar echinococcosis: systematic review and meta-analysis. PLoS Negl Trop Dis. 2017;11:e0005801.CrossRefPubMedPubMedCentral
20.
go back to reference Bresson-Hadni S, Laplante JJ, Lenys D, Rohmer P, Gottstein B, Jacquier P, Mercet P, Meyer JP, Miguet JP, Vuitton DA. Seroepidemiologic screening of echinococcus multilocularis infection in a European area endemic for alveolar echinococcosis. Am J Trop Med Hyg. 1994;51:837–46.CrossRefPubMed Bresson-Hadni S, Laplante JJ, Lenys D, Rohmer P, Gottstein B, Jacquier P, Mercet P, Meyer JP, Miguet JP, Vuitton DA. Seroepidemiologic screening of echinococcus multilocularis infection in a European area endemic for alveolar echinococcosis. Am J Trop Med Hyg. 1994;51:837–46.CrossRefPubMed
21.
go back to reference Reuter S, Buck A, Manfras B, Kratzer W, Seitz HM, Darge K, Reske SN, Kern P. Structured treatment interruption in patients with alveolar echinococcosis. Hepatology. 2004;39:509–17.CrossRefPubMed Reuter S, Buck A, Manfras B, Kratzer W, Seitz HM, Darge K, Reske SN, Kern P. Structured treatment interruption in patients with alveolar echinococcosis. Hepatology. 2004;39:509–17.CrossRefPubMed
22.
go back to reference Nunnari G, Pinzone MR, Gruttadauria S, Celesia BM, Madeddu G, Malaguarnera G, Pavone P, Cappellani A, Cacopardo B. Hepatic echinococcosis: clinical and therapeutic aspects. World J Gastroenterol. 2012;18:1448–58.CrossRefPubMedPubMedCentral Nunnari G, Pinzone MR, Gruttadauria S, Celesia BM, Madeddu G, Malaguarnera G, Pavone P, Cappellani A, Cacopardo B. Hepatic echinococcosis: clinical and therapeutic aspects. World J Gastroenterol. 2012;18:1448–58.CrossRefPubMedPubMedCentral
23.
go back to reference Vuitton DA. Benzimidazoles for the treatment of cystic and alveolar echinococcosis: what is the consensus? Expert Rev Anti Infect Ther. 2009;7:145–9.CrossRefPubMed Vuitton DA. Benzimidazoles for the treatment of cystic and alveolar echinococcosis: what is the consensus? Expert Rev Anti Infect Ther. 2009;7:145–9.CrossRefPubMed
24.
go back to reference Reuter S, Jensen B, Buttenschoen K, Kratzer W, Kern P. Benzimidazoles in the treatment of alveolar echinococcosis: a comparative study and review of the literature. J Antimicrob Chemother. 2000;46:451–6.CrossRefPubMed Reuter S, Jensen B, Buttenschoen K, Kratzer W, Kern P. Benzimidazoles in the treatment of alveolar echinococcosis: a comparative study and review of the literature. J Antimicrob Chemother. 2000;46:451–6.CrossRefPubMed
25.
go back to reference Torgerson PR, Schweiger A, Deplazes P, Pohar M, Reichen J, Ammann RW, Tarr PE, Halkik N, Müllhaupt B. Alveolar echinococcosis: from a deadly disease to a well-controlled infection. Relative survival and economic analysis in Switzerland over the last 35 years. J Hepatol. 2008;49:72–7.CrossRefPubMed Torgerson PR, Schweiger A, Deplazes P, Pohar M, Reichen J, Ammann RW, Tarr PE, Halkik N, Müllhaupt B. Alveolar echinococcosis: from a deadly disease to a well-controlled infection. Relative survival and economic analysis in Switzerland over the last 35 years. J Hepatol. 2008;49:72–7.CrossRefPubMed
27.
go back to reference King CH, Bertino AM. Asymmetries of poverty: why global burden of disease valuations underestimate the burden of neglected tropical diseases. PLoS Negl Trop Dis. 2008;2:e209.CrossRefPubMedPubMedCentral King CH, Bertino AM. Asymmetries of poverty: why global burden of disease valuations underestimate the burden of neglected tropical diseases. PLoS Negl Trop Dis. 2008;2:e209.CrossRefPubMedPubMedCentral
28.
go back to reference Bullinger M. Das Konzept der Lebensqualität in der Medizin: Entwicklung und heutiger Stellenwert. Lebensqualität im Gesundheitswesen: Wissen wir, was wir tun? (2013). Bullinger M. Das Konzept der Lebensqualität in der Medizin: Entwicklung und heutiger Stellenwert. Lebensqualität im Gesundheitswesen: Wissen wir, was wir tun? (2013).
29.
go back to reference Bullinger M, Kirchberger I. SF-36 Fragebogen zum Gesundheitszustand. Handanweisung: Hogrefe Verlag für Psychologie Göttingen; 1998. Bullinger M, Kirchberger I. SF-36 Fragebogen zum Gesundheitszustand. Handanweisung: Hogrefe Verlag für Psychologie Göttingen; 1998.
30.
go back to reference Ellert U, Kurth BM. Gesundheitsbezogene Lebensqualität bei Erwachsenen in Deutschland. Bundesgesundheitsblatt-Gesundheitsforschung-Gesundheitsschutz. 2013;56(5–6):643–9.CrossRefPubMed Ellert U, Kurth BM. Gesundheitsbezogene Lebensqualität bei Erwachsenen in Deutschland. Bundesgesundheitsblatt-Gesundheitsforschung-Gesundheitsschutz. 2013;56(5–6):643–9.CrossRefPubMed
33.
34.
go back to reference Pal B, Murti K, Siddiqui NA, Das P, Lal CS, Babu R, Rastogi MK, Pandey K. Assessment of quality of life in patients with post kalaazar dermal leishmaniasis. Health Qual Life Outcomes. 2017;15:148.CrossRefPubMedPubMedCentral Pal B, Murti K, Siddiqui NA, Das P, Lal CS, Babu R, Rastogi MK, Pandey K. Assessment of quality of life in patients with post kalaazar dermal leishmaniasis. Health Qual Life Outcomes. 2017;15:148.CrossRefPubMedPubMedCentral
35.
go back to reference Sileshi L, Tefera E. Health-related quality of life of mothers of children with congenital heart disease in a sub-Saharan setting: cross-sectional comparative study. BMC Res Notes. 2017;10:513.CrossRefPubMedPubMedCentral Sileshi L, Tefera E. Health-related quality of life of mothers of children with congenital heart disease in a sub-Saharan setting: cross-sectional comparative study. BMC Res Notes. 2017;10:513.CrossRefPubMedPubMedCentral
36.
go back to reference Kalter J, Verdonck-de Leeuw IM, Sweegers MG, Aaronson NK, Jacobsen PB, Newton RU, Courneya KS, Aitken JF, Armes J, Arving C, Boersma LJ, Braamse AM, Brandberg Y, Chambers SK, Dekker J, Ell K, Ferguson RJ, Gielissen MF, Glimelius B, Goedendorp MM, Graves KD, Heiney SP, Horne R, Hunter MS, Johansson B, Kimman ML, Knoop H, Meneses K, Northouse LL, Oldenburg HS, Prins JB, Savard J, van Beurden M, van den Berg SW, Brug J, Buffart LM. Effects and moderators of psychosocial interventions on quality of life, and emotional and social function in patients with cancer: an individual patient data meta-analysis of 22 RCTs. Psychooncology. 2018;27:1150–61.CrossRefPubMedPubMedCentral Kalter J, Verdonck-de Leeuw IM, Sweegers MG, Aaronson NK, Jacobsen PB, Newton RU, Courneya KS, Aitken JF, Armes J, Arving C, Boersma LJ, Braamse AM, Brandberg Y, Chambers SK, Dekker J, Ell K, Ferguson RJ, Gielissen MF, Glimelius B, Goedendorp MM, Graves KD, Heiney SP, Horne R, Hunter MS, Johansson B, Kimman ML, Knoop H, Meneses K, Northouse LL, Oldenburg HS, Prins JB, Savard J, van Beurden M, van den Berg SW, Brug J, Buffart LM. Effects and moderators of psychosocial interventions on quality of life, and emotional and social function in patients with cancer: an individual patient data meta-analysis of 22 RCTs. Psychooncology. 2018;27:1150–61.CrossRefPubMedPubMedCentral
37.
go back to reference Schmidberger J. Influence of self-help on health-relevant quality of life—a study in dialysis patients with end-stage renal disease. Dialyse Aktuell. 2016;20:95–100.CrossRef Schmidberger J. Influence of self-help on health-relevant quality of life—a study in dialysis patients with end-stage renal disease. Dialyse Aktuell. 2016;20:95–100.CrossRef
Metadata
Title
Health-related quality of life in patients with alveolar echinococcosis: a cross-sectional study
Authors
Julian Schmidberger
Henriette Weimer
Patrycja Schlingeloff
Wolfgang Kratzer
Beate Grüner
Echinococcosis Working Group, Ulm
Publication date
01-02-2019
Publisher
Springer Berlin Heidelberg
Published in
Infection / Issue 1/2019
Print ISSN: 0300-8126
Electronic ISSN: 1439-0973
DOI
https://doi.org/10.1007/s15010-018-1219-0

Other articles of this Issue 1/2019

Infection 1/2019 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.